Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Education and public awareness are crucial for patients navigating BCG-unresponsive non-muscle invasive bladder cancer treatment options.

Muscle-invasive bladder cancer management is challenging for cisplatin-ineligible patients due to limited treatment options and high recurrence rates. The Padcev-Keytruda combination therapy ...

Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a ...

Cancer patients are going without treatment as they await repairs at the Oklahoma Proton Center in Oklahoma City.

National Cancer Awareness Day is celebrated in India to raise awareness about cancer, and the prevention and treatment of the ...

UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding phase 1 data for the bladder cancer drug didn’t ...

October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from ...

India faces a worrying rise in cancer cases. Doctors Gopal Sharma and Rakesh Kumar Agarwal explain pollution, diet, obesity, ...

Demonstrates PPARG inhibition as a potential strategy to overcome immune resistance in advanced UC− Supports the planned Phase 1 cohort of ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced robust preliminary ...